Copyright 2024
| PMID | Allele | Disease | Population | Drug Names | SNP | Class | Sentence |
|---|---|---|---|---|---|---|---|
| 21145259 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | lung transplantation | NA | NA | NA | negation | |
| human leukocyte antigen (hla) histocompatibility is not considered when placing donor allografts for lung transplantation. | |||||||
| 21145259 | HLA (HLA) | lung transplantation | NA | NA | NA | unclassified | |
| these data suggest that donor-recipient hla mm may warrant consideration when allocating organs for lung transplantation. | |||||||
| 21145259 | HLA (HLA) | bronchiolitis obliterans | NA | NA | NA | unclassified | |
| hla mismatches influence lung transplant recipient survival, bronchiolitis obliterans and rejection: implications for donor lung allocation. | |||||||
| 21145259 | HLA (HLA) | bronchiolitis obliterans | NA | NA | NA | unclassified | |
| in this study we evaluated whether the effects of total hla, class i and class ii mm were more important determinants of: (1) recipient survival; (2) development of bronchiolitis obliterans (bo); and (3) freedom from acute rejection (ar). | |||||||
| 22370964 | HLA (HLA) | lung transplantation | NA | NA | NA | positive | |
| furthermore, the lung graft was from her husband and hla analysis on the recipient's daughter revealed the same donor-specific hla antigens, which strongly suggested pre-sensitization before lung transplantation. | |||||||
| 23995373 | HUMAN LEUKOCYTE ANTIGEN (HUMAN LEUKOCYTE ANTIGEN) | lung transplantation | NA | NA | NA | unclassified | |
| advancements in human leukocyte antigen antibody testing and use of extracorporeal membrane oxygenation as a bridge to lung transplantation have additionally impacted recipient selection standards.summaryrecipient selection criteria continue to evolve because of advances in mechanical bridging to transplant and postoperative management. | |||||||
| 24749479 | HLA (HLA) | lung transplantation | NA | NA | NA | only_studied | |
| swe examined the prevalence of pretransplant anti-hla antibodies at varying thresholds and evaluated their impact on outcomes before and after lung transplantation. | |||||||
| 24954882 | HLA (HLA) | lung transplantation | NA | NA | NA | unclassified | |
| pre-transplant donor hla-specific antibodies: characteristics causing detrimental effects on survival after lung transplantation. | |||||||
| 24954882 | HLA (HLA) | lung transplantation | NA | NA | NA | unclassified | |
| the impact of luminex-detected hla antibodies on outcomes after lung transplantation is unclear. | |||||||
| 25070908 | HLA (HLA) | lung transplantation | NA | NA | NA | unclassified | |
| the impact of early donor-specific anti-hla antibodies (dsa) on patient and graft survival after lung transplantation remains controversial. | |||||||
Copyright 2024